CYP-eicosanoids—A new link between omega-3 fatty acids and cardiac disease?

Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94 Lavie, 2009, Omega-3 polyunsaturated fatty acids and cardiovascular diseases, J Am Coll Cardiol, 54, 585, 10.1016/j.jacc.2009.02.084 De Caterina, 2011, n-3 fatty acids in cardiovascular disease, N Engl J Med, 364, 2439, 10.1056/NEJMra1008153 Lands, 2005, Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease, Ann N Y Acad Sci, 1055, 179, 10.1196/annals.1323.028 Leaf, 2003, Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils, Circulation, 107, 2646, 10.1161/01.CIR.0000069566.78305.33 Mozaffarian, 2008, Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death, Am J Clin Nutr, 87, 1991S, 10.1093/ajcn/87.6.1991S Matthan, 2005, A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models, Metabolism, 54, 1557, 10.1016/j.metabol.2005.05.026 Fischer, 2008, Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension, Hypertension, 51, 540, 10.1161/HYPERTENSIONAHA.107.103143 Gao, 2011, Long-term treatment with eicosapentaenoic acid ameliorates myocardial ischemia–reperfusion injury in pigs in vivo, Circ J, 75, 1843, 10.1253/circj.CJ-11-0209 Sarrazin, 2007, Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs, J Am Coll Cardiol, 50, 1505, 10.1016/j.jacc.2007.05.046 Kitamura, 2011, Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model, Am J Physiol Heart Circ Physiol, 300, H1814, 10.1152/ajpheart.00771.2010 Marchioli, 2002, Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione, Circulation, 105, 1897, 10.1161/01.CIR.0000014682.14181.F2 Calo, 2005, N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial, J Am Coll Cardiol, 45, 1723, 10.1016/j.jacc.2005.02.079 Virtanen, 2009, Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men, Circulation, 120, 2315, 10.1161/CIRCULATIONAHA.109.852657 Benedetto, 2011, n-3 polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials, J Cardiovasc Med (Hagerstown), 10.2459/JCM.0b013e32834a13c1 Dyerberg, 1978, Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?, Lancet, 2, 117, 10.1016/S0140-6736(78)91505-2 Arterburn, 2006, Distribution, interconversion, and dose response of n-3 fatty acids in humans, Am J Clin Nutr, 83, 1467S, 10.1093/ajcn/83.6.1467S Simopoulos, 2008, The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases, Exp Biol Med (Maywood), 233, 674, 10.3181/0711-MR-311 Mozaffarian, 2006, Fish intake, contaminants, and human health: evaluating the risks and the benefits, JAMA, 296, 1885, 10.1001/jama.296.15.1885 von Schacky, 2007, Cardiovascular benefits of omega-3 fatty acids, Cardiovasc Res, 73, 310, 10.1016/j.cardiores.2006.08.019 Harris, 2008, The omega-3 index as a risk factor for coronary heart disease, Am J Clin Nutr, 87, 1997S, 10.1093/ajcn/87.6.1997S Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041 Wada, 2007, Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products, J Biol Chem, 282, 22254, 10.1074/jbc.M703169200 Shikano, 1994, Complete discrimination of docosahexaenoate from arachidonate by 85kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine, Biochim Biophys Acta, 1212, 211, 10.1016/0005-2760(94)90255-0 Rapoport, 2008, Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease, Prostaglandins Leukot Essent Fatty Acids, 79, 153, 10.1016/j.plefa.2008.09.010 Rosa, 2009, Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids, Biochim Biophys Acta, 1791, 697, 10.1016/j.bbalip.2009.03.009 Jenkins, 2009, Eicosanoid signalling pathways in the heart, Cardiovasc Res, 82, 240, 10.1093/cvr/cvn346 Sharma, 2011, PGE2 release from tryptase-stimulated rabbit ventricular myocytes is mediated by calcium-independent phospholipase A2gamma, Lipids, 46, 391, 10.1007/s11745-011-3554-0 Terano, 1984, Biosynthesis and biological activity of leukotriene B5, Prostaglandins, 27, 217, 10.1016/0090-6980(84)90075-3 Jump, 2002, The biochemistry of n-3 polyunsaturated fatty acids, J Biol Chem, 277, 8755, 10.1074/jbc.R100062200 Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294 Serhan, 2009, Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions, J Exp Med, 206, 15, 10.1084/jem.20081880 Keyes, 2010, Resolvin E1 protects the rat heart against reperfusion injury, Am J Physiol Heart Circ Physiol, 299, H153, 10.1152/ajpheart.01057.2009 Capdevila, 2000, Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase, J Lipid Res, 41, 163, 10.1016/S0022-2275(20)32049-6 McGiff, 1999, 20-HETE and the kidney: resolution of old problems and new beginnings, Am J Physiol, 277, R607 Roman, 2002, P-450 metabolites of arachidonic acid in the control of cardiovascular function, Physiol Rev, 82, 131, 10.1152/physrev.00021.2001 Zeldin, 2001, Epoxygenase pathways of arachidonic acid metabolism, J Biol Chem, 276, 36059, 10.1074/jbc.R100030200 Konkel, 2011, Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids, Biochim Biophys Acta, 1814, 210, 10.1016/j.bbapap.2010.09.009 Barbosa-Sicard, 2005, Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily, Biochem Biophys Res Commun, 329, 1275, 10.1016/j.bbrc.2005.02.103 Fer, 2008, Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450, Arch Biochem Biophys, 471, 116, 10.1016/j.abb.2008.01.002 Arnold, 2010, Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids, J Biol Chem, 285, 32720, 10.1074/jbc.M110.118406 Lucas, 2010, Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450, J Lipid Res, 51, 1125, 10.1194/jlr.M003061 Knapp, 1991, Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man, Prostaglandins, 42, 47, 10.1016/0090-6980(91)90093-U Shearer, 2010, Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters, J Lipid Res, 51, 2074, 10.1194/M900193-JLR200 Capdevila, 2002, Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases, Prostaglandins Other Lipid Mediat, 68–69, 325, 10.1016/S0090-6980(02)00038-2 Zeldin, 1993, Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase, J Biol Chem, 268, 6402, 10.1016/S0021-9258(18)53266-X Zeldin, 1995, Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis, Arch Biochem Biophys, 316, 443, 10.1006/abbi.1995.1059 Karara, 1991, Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties, J Biol Chem, 266, 7561, 10.1016/S0021-9258(20)89484-8 Capdevila, 2007, Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension, Kidney Int, 72, 683, 10.1038/sj.ki.5002394 Campbell, 2007, Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors, Hypertension, 49, 590, 10.1161/01.HYP.0000255173.50317.fc Fleming, 2008, Vascular cytochrome p450 enzymes: physiology and pathophysiology, Trends Cardiovasc Med, 18, 20, 10.1016/j.tcm.2007.11.002 Nithipatikom, 2010, Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection, J Cardiovasc Pharmacol Ther, 15, 112, 10.1177/1074248409358408 Nithipatikom, 2004, Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway, Circ Res, 95, e65, 10.1161/01.RES.0000146277.62128.6f Seubert, 2007, Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury, Prostaglandins Other Lipid Mediat, 82, 50, 10.1016/j.prostaglandins.2006.05.017 Gross, 2005, Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited, Cardiovasc Res, 68, 18, 10.1016/j.cardiores.2005.06.007 Wu, 1997, Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes, J Biol Chem, 272, 12551, 10.1074/jbc.272.19.12551 Seubert, 2004, Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway, Circ Res, 95, 506, 10.1161/01.RES.0000139436.89654.c8 Batchu, 2009, Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model, J Mol Cell Cardiol, 46, 67, 10.1016/j.yjmcc.2008.09.711 Gross, 2007, Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts, J Mol Cell Cardiol, 42, 687, 10.1016/j.yjmcc.2006.11.020 Gross, 2008, Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart, Am J Physiol Heart Circ Physiol, 294, H2838, 10.1152/ajpheart.00186.2008 Gross, 2009, Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog, Am J Physiol Heart Circ Physiol, 297, H47, 10.1152/ajpheart.01084.2008 Yu, 2011, Cytochrome P450 2J3/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat, Clin Exp Pharmacol Physiol, 38, 63, 10.1111/j.1440-1681.2010.05464.x Gross, 2011, Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts, Cardiovasc Drugs Ther, 10.1007/s10557-011-6321-9 Zhang, 2009, Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity, Am J Physiol Heart Circ Physiol, 297, H37, 10.1152/ajpheart.00983.2008 Xu, 2006, Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors, Proc Natl Acad Sci USA, 103, 18733, 10.1073/pnas.0609158103 Ai, 2009, Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy, Proc Natl Acad Sci USA, 106, 564, 10.1073/pnas.0811022106 Monti, 2008, Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease, Nat Genet, 40, 529, 10.1038/ng.129 Nithipatikom, 2001, Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs, Anal Biochem, 292, 115, 10.1006/abio.2001.5044 Gross, 2004, Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel, J Mol Cell Cardiol, 37, 1245 Nithipatikom, 2006, Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection, Am J Physiol Heart Circ Physiol, 290, H500, 10.1152/ajpheart.00918.2005 Yousif, 2009, Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic–reperfusion injury, Auton Autacoid Pharmacol, 29, 33, 10.1111/j.1474-8673.2009.00429.x Node, 1999, Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids, Science, 285, 1276, 10.1126/science.285.5431.1276 Rompe, 2010, Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB, Hypertension, 55, 924, 10.1161/HYPERTENSIONAHA.109.147843 Bodiga, 2009, Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels, J Mol Cell Cardiol, 46, 978, 10.1016/j.yjmcc.2009.01.009 Katragadda, 2009, Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells, J Mol Cell Cardiol, 46, 867, 10.1016/j.yjmcc.2009.02.028 Xiao, 1998, Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells, J Physiol, 508, 777, 10.1111/j.1469-7793.1998.777bp.x Xiao, 2007, Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids, Prostaglandins Other Lipid Mediat, 82, 11, 10.1016/j.prostaglandins.2006.05.023 Lu, 2001, Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes, J Physiol, 537, 811, 10.1113/jphysiol.2001.012896 Lee, 1999, Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes, J Physiol, 519, 153, 10.1111/j.1469-7793.1999.0153o.x Hausenloy, 2005, The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning, Trends Cardiovasc Med, 15, 69, 10.1016/j.tcm.2005.03.001 Gross, 2004, Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts, Circ Res, 94, 960, 10.1161/01.RES.0000122392.33172.09 Li, 2009, Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches, J Mol Cell Cardiol, 47, 835, 10.1016/j.yjmcc.2009.08.017 Brown, 2010, Cardiac mitochondria and arrhythmias, Cardiovasc Res, 88, 241, 10.1093/cvr/cvq231 Miura, 2010, Role of the gap junction in ischemic preconditioning in the heart, Am J Physiol Heart Circ Physiol, 298, H1115, 10.1152/ajpheart.00879.2009 Singh, 2007, Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension, Hypertension, 50, 123, 10.1161/HYPERTENSIONAHA.107.089599 Ishizuka, 2008, 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells, J Pharmacol Exp Ther, 324, 103, 10.1124/jpet.107.130336 Cheng, 2010, 20-Hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling, J Pharmacol Exp Ther, 332, 57, 10.1124/jpet.109.159863 Muthalif, 1998, 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells, Proc Natl Acad Sci USA, 95, 12701, 10.1073/pnas.95.21.12701 Yaghi, 2005, Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle, Am J Physiol Lung Cell Mol Physiol, 289, L1061, 10.1152/ajplung.00096.2005 Zeng, 2010, 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes, Am J Physiol Heart Circ Physiol, 299, H1109, 10.1152/ajpheart.00067.2010 Bao, 2011, 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways, J Cardiovasc Pharmacol, 57, 294 Lu, 2002, Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study, Mol Pharmacol, 62, 1076, 10.1124/mol.62.5.1076 Hercule, 2007, The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents, Exp Physiol, 92, 1067, 10.1113/expphysiol.2007.038166 Lauterbach, 2002, Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators, Hypertension, 39, 609, 10.1161/hy0202.103293 Ye, 2002, Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels, J Pharmacol Exp Ther, 303, 768, 10.1124/jpet.303.2.768 Zhang, 2001, EET homologs potently dilate coronary microvessels and activate BK(Ca) channels, Am J Physiol Heart Circ Physiol, 280, H2430, 10.1152/ajpheart.2001.280.6.H2430 Morin, 2010, 17,18-Epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase, Am J Respir Cell Mol Biol, 43, 564, 10.1165/rcmb.2009-0155OC Morin, 2009, Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung, Am J Physiol Lung Cell Mol Physiol, 296, L130, 10.1152/ajplung.90436.2008 Kang, 1994, Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes, Proc Natl Acad Sci USA, 91, 9886, 10.1073/pnas.91.21.9886 Kang, 1995, Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes, Biochem Biophys Res Commun, 208, 629, 10.1006/bbrc.1995.1385 Kang, 1995, Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes, Proc Natl Acad Sci USA, 92, 3997, 10.1073/pnas.92.9.3997 Falck, 2011, 17(R),18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure–activity relationships and stable analogues, J Med Chem, 54, 4109, 10.1021/jm200132q Spector, 2009, Arachidonic acid cytochrome P450 epoxygenase pathway, J Lipid Res, 50, S52, 10.1194/jlr.R800038-JLR200 Chen, 2009, 20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site, J Pharmacol Exp Ther, 331, 1137, 10.1124/jpet.109.157818 Chen, 2011, 20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor, Biochemistry, 50, 3840, 10.1021/bi102070w Li, 1997, Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein, Circ Res, 80, 877, 10.1161/01.RES.80.6.877 Schwarz, 2005, Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns, Biochem Biophys Res Commun, 336, 779, 10.1016/j.bbrc.2005.08.172 Fer, 2008, Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism, J Lipid Res, 49, 2379, 10.1194/jlr.M800199-JLR200 Muller, 2007, Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation, Biochem J, 403, 109, 10.1042/BJ20061328 Harmon, 2006, Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production, Prostaglandins Leukot Essent Fatty Acids, 75, 169, 10.1016/j.plefa.2006.05.005 Stark, 2005, Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8, Arch Biochem Biophys, 441, 174, 10.1016/j.abb.2005.07.003 Schwarz, 2004, Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid, Biochem Pharmacol, 67, 1445, 10.1016/j.bcp.2003.12.023 Capdevila, 1996, The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3, J Biol Chem, 271, 22663, 10.1074/jbc.271.37.22663 Russo, 2009, Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention, Biochem Pharmacol, 77, 937, 10.1016/j.bcp.2008.10.020 Wu, 1996, Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart, J Biol Chem, 271, 3460, 10.1074/jbc.271.7.3460